Parkinson disease: Do we need to improve treatment strategies that focus on nonmotor complications such as pain?

Nature Clinical Practice Neurology

Volumn 4, Issue 9, 2008, Pages 478-479

  Ludwig, Janne ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; LEVODOPA;

CAUSAL ATTRIBUTION; CHRONIC PAIN; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; LONG TERM CARE; MOTOR DYSFUNCTION; NEUROPATHIC PAIN; NOCICEPTION; NOTE; ONSET AGE; PAIN ASSESSMENT; PAIN THRESHOLD; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; SYMPTOMATOLOGY; VISUAL ANALOG SCALE;

EID: 51849139080     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0882     Document Type: Note

References (8)

1. Parkinson J (1817) An Essay on the Shaking Palsy. London: Sherwood, Neely and Jones
2. Wasner G and Deuschl G (2006) Pain in Parkinson's disease. In Pain 747-760 (Eds Cervero F and Jensen TS) Amsterdam: Elsevier [Aminoff MJ et al. (Series Eds) Handbook of Clinical Neurology, vol 81]
3. Goetz CG et al. (1986) Pain in Parkinson's disease. Mov Disord 1: 45-49
4. Baron R (2006) Mechanisms of Disease: Neuropathic pain - a clinical perspective. Nat Clin Pract Neurol 2: 95-106
5. Nère-Pagès et al. (2008) Chronic pain in Parkinson's disease: The cross-sectional French DoPaMiP survey. Mov Disord 23: 1361-1369
6. Sage JI (2004) Pain in Parkinson's disease. Curr Treat Options Neurol 6: 191-200
7. Gerdelat-Mas A et al. (2007) Levodopa raises objective pain threshold in Parkinson's disease: A RIII reflex study. J Neurol Neurosurg Psychiatr 78: 1140-1142
8. Brefel-Courbon C et al. (2005) Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study. Mov Disord 20: 1557-1563